To speed up vaccination in India: Cipla gets nod to import Moderna's Covid vaccine for emergency use
Cipla, The leading pharmaceutical company, has approached the Drug Controller General of India for a green signal to use the 'Moderna' Covid vaccine for emergency use in the country. Cipla distributes Moderna's Covid-19 vaccine in India
On Monday, Mumbai-based pharmaceutical company Cipla approached the Drug Controller seeking permission to import the Moderna vaccine.
Moderna is said to be 90 percent effective against Covid: Moderna vaccine, which is 90% resistant against Covid-19, is widely accepted in many parts of the world.
The opinions posted here are not those of BizGlob. The author is solely responsible for the comments. According to the IT policy of the Central Government, insulting and obscene language against an individual, community, religion, or country is a punishable offence. Such expressions will be prosecuted.
Add your comments to To speed up vaccination in India: Cipla gets nod to import Moderna's Covid vaccine for emergency use
Send your enquiries, articles, copyright issues, or advertisement requests to bizglobadvt@gmail.com
Disclaimer: All content on this website, including article, video, photographs, biography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
